Immucell Corp ICCC
$10.06
-0.30%
at last close
Financials (TTM)
- Revenue
- $30.68 million
- Net Income
- $787,373
- Net Margin
- 2.57%
- Return on Equity
- 2.51%
- Debt-to-Equity
- 0.26
- P/E Ratio
- 143.71
- Price / Book
- 2.91
- Price / Sales
- 2.98
Over the trailing twelve months, Immucell Corp generated revenue of $30.68 million and net income of $787,373, a net margin of 2.57%.
At the last closing price of $10.06, ICCC trades at 143.71 times trailing earnings and 2.98 times sales, with a market capitalization of $91.37 million.
Key Stats
- Last Close
- $10.06
- Market Cap
- $91.37 million
- 52-Week Range
- $4.52 – $12.10
- Average Volume
- 31K shs
Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.